Showing results (261-270 of 351) with videos related to
Sort By:
Pageof 36
European Journal of Haematology|October 6, 2007
Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or olderKi-Seong Eom, Hee-Je Kim, Woo-Sung Min, et al.Annals of Hematology|September 7, 2011
Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantationByung-Sik Cho, Ji-Young Lim, Seung-Ah Yahng, et al.Journal for Immunotherapy of Cancer|February 9, 2019
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantationSung-Eun Lee, Ji-Young Lim, Tae Woo Kim, et al.Immune Network|September 2, 2017
Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple MyelomaKhishigjargal Batsukh, Sung-Eun Lee, Gi June Min, et al.British Journal of Haematology|November 26, 2013
Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphomaSeung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2018
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic SyndromeSung-Soo Park, Young-Woo Jeon, Gi June Min, et al.Annals of Hematology|June 26, 2018
Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatmentSung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, et al.Leukemia & Lymphoma|May 8, 2013
Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemiaJae-Ho Yoon, Hee-Je Kim, Seung-Hwan Shin, et al.American Journal of Hematology|August 29, 2013
Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance statusJae-Ho Yoon, Byung-Sik Cho, Hee-Je Kim, et al.Biomed Research International|March 8, 2018
Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple MyelomaSung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, et al.Pageof 36